VCO, lagundi help mild COVID-19 patients: DOST study

Jasmin Romero, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img alt=" Lagundi tree. ABS-CBN News" src="https://sa.kapamilya.com/absnews/abscbnnews/media/2021/news/10/26/20210703-lagundi-tree-gcs-174759.jpg"/><figcaption>Lagundi tree. <em>ABS-CBN News</em></figcaption></figure></div><p><br/>MANILA— A study of the Department of Science and Technology has found that virgin coconut oil (VCO) and lagundi can help with patients with mild cases of COVID-19.</p><p>Community trials for VCO conducted on 57 adults with suspect and probable COVID-19 cases found that it can be used as “adjunct supplement” to “suspect and probable cases due to its immunomodulatory properties.”</p><p>“Because of its preventive effect that we have found in our study, wherein it really had diminished the signs and symptoms as early as two days for those patients given VCO, as compared to those without the VCO,” said Dr. Imelda Angeles-Agdeppa, director of the DOST Food and Nutrition Research Institute.</p><p>The participants took VCO based on body weight, 0.6 ml/kg of VCO daily for the first 3 days, and 1.2 ml/kg of VCO daily for the next 4 to 28 days.</p><p>The DOST also conducted VCO hospital trials on 77 adult patients with COVID-19, regardless of the severity of their diseases with 15 ml of VCO 3 times a day for 14 days.</p><p>There was “no established benefit yet for hospitalized patients as trial results (are) still ongoing,” the DOST said.</p><p>“Further study at the molecular level is needed to determine actual effects using VCO among hospitalized patients,” it added.</p><p>The DOST also found “promising results” on the effects of lagundi in “decreasing the symptoms during mild COVID disease, especially for anosmia,” or loss of sense of smell patients usually complain about.</p><p>“Napatunayan na overall ang mga sintomas na mas mabilis na mas maganda ang nangyari sa mga binigyan ng lagundi kumpara doon sa mga di binigyan ng lagundi,” said Dr. Jaime Montoya, executive director of the DOST-Philippine Council for Health Research and Development.</p><p>(Overall, we have proven that symptoms go away faster among those given lagundi versus those who did not receive it.)</p><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1717176" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

A DOST study has found that virgin coconut oil (VCO) and lagundi can help with patients with mild cases of COVID-19.

VCO, lagundi help mild COVID-19 patients: DOST study | ABS-CBN

Halalan 2025

Entertainment

News

Metro.Style

Lifestyle

Sports

More

Traffic

Horoscope

News

VCO, lagundi help mild COVID-19 patients: DOST study

VCO, lagundi help mild COVID-19 patients: DOST study

Jasmin Romero,

ABS-CBN News

Published Oct 26, 2021 04:13 PM PHT

Read More:

COVID-19

VCO

Lagundi

adjunct supplement

virgin coconut oil

DOST

Department of Science and Technology

Imelda Angeles-Agdeppa

Jaime Montoya

VCO COVID

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.